Immunology Primer 101 reveals the intricate workings of the human immune system, highlighting the difference between non-specific and specific immunity. It uncovers the mysteries of how our bodies combat cancer and infections, exploring the roles of immune cells and tissues acting in our defense. This class showcases the remarkable link between our natural defenses and headline grabbing therapeutic antibodies developed by the biopharmaceutical industry. These therapies have revolutionized disease treatment for a host of diseases. Immunology Primer 101 is the perfect starting point for those new to understanding immunotherapies. Don't miss the chance to join us!

Protein-Based Diagnostics Primer is an extensive tutorial on protein-based diagnostics commonly used in disease detection in the research and clinic setting. This engaging class covers various tools, including immunoassays, multiplexed assays, lateral flow assays, and chromatography. Get ready to explore the science of ELISA and bead immunoassays, two quantitative diagnostics that measure multiple proteins simultaneously. This course also takes a closer look at Lateral Flow Assay (LFA) technology, a rapid detection diagnostic for target-specific biomarkers. To round out the agenda, this primer ends with an in-depth exploration of chromatography technologies used for protein separation, purification, and analysis. Grab your spot today to gain a deep understanding of these different protein-based diagnostics and their practical implications!

DNA-Based Diagnostics Primer is the ultimate guide to the molecular science behind standard diagnostic tools used in research and clinical settings. This primer breaks down the critical technology that drives these diagnostic advancements, including Polymerase Chain Reaction (PCR), microarrays, Next-Generation Sequencing (NGS), and microRNA diagnostics. Each diagnostic tool is thoroughly explained, highlighting its purpose, when it is used, and how it harnesses the power of DNA to detect and analyze specific genetic sequences. This class provides a comprehensive understanding of the scientific principles that underpin DNA-based diagnostics. Gain entry into the fast-paced field of DNA-molecular diagnostics by registering for this course today

Drug Discovery of Biologics Primer 201 builds upon the foundational knowledge of Drug Discovery of Biologics Primer 101, focusing on systematic insights into therapeutic antibody discovery. This course begins with the significance of antibody screening and structure-based affinity maturation, emphasizing antibody Chemistry, Manufacturing, and Controls (CMC) liabilities. Covering four therapeutic antibody classes, including immune checkpoint inhibitors, this class showcases the factors that influence early drug candidate selection. The data and transition criteria essential for advancing candidate drugs from the discovery phase to preclinical development are also covered. Enroll today to deepen your therapeutic antibody drug discovery knowledge!

Small Molecule Drug Discovery Primer 101 teaches the essential steps to finding and bringing new compounds to market. From identifying potential drug targets to optimizing lead compounds, this class demonstrates how scientists refine small molecule drugs before they undergo preclinical and clinical trials. Discover how proven techniques like computational modeling, in vitro testing, and animal studies are crucial in identifying promising medicinal options. Don't miss this opportunity to become conversant in the fast-paced world of pharmaceutical research!

Drug Discovery of Biologics Primer 101 is a must-have class for those new to medicines derived from living organisms. It delves deep into the five-step drug discovery process, spanning target identification and verification to candidate identification, validation, and optimization. This class reveals the utility of in silico, in vitro, and in vivo disease models in elucidating functional pharmacology activity. Drug Discovery of Biologics Primer 101 ends by demonstrating how the data analysis is used to make crucial candidate drug go or no-go decisions. Seize this opportunity to learn the fundamentals of biologics drug discovery. Reserve your spot now

Diagnostics' Role in Medicine Today introduces the ever-expanding molecular diagnostics industry. This class defines the groundbreaking field of qualitative and quantitative biomarker measurements. These crucial measurements help identify diseases, select treatments, and monitor chosen therapies. Get ready to explore a wide range of foundational diagnostics used in both research and clinical settings, such as immunochemistry, microbiology, and infectious disease diagnostics. The course ends by focusing on companion diagnostics. The showstopper is a culminating case study on HER2 cancer/Herceptin that highlights real-world evidence of how companion diagnostics help patients receive appropriate therapy. Learn foundational concepts applied in the research and clinic settings and become diagnostic proficient, enroll today!

Diagnostic Development Primer is a comprehensive guide to navigating the complex world of approval pathways. This class begins by examining the vital roles that various United States government agencies play in regulating In Vitro Diagnostics (IVD) and Laboratory-Developed Tests (LDTs). It provides a detailed description of the regulatory requirements for Class I, II, and III diagnostic approval pathways. A review of the internationally recognized Quality System Regulations (QSR) and how they impact the design and manufacturing of diagnostic products closes out section two. This primer wraps up by explaining the reimbursement process for Medicare, Medicaid, hospitals, and private payers, breaking down complex inpatient DRG codes and outpatient CPT codes. Enroll now in the Diagnostic Approval Primer and become well-versed in the approval process of molecular diagnostics. Let's start your journey today!

Clinical Development 401: Phase IV uncovers what happens after a new drug gains approval and enters the marketplace. This class, the 4th and final in the comprehensive Biotech Primer Clinical Development series, exposes the crucial role of regulatory agencies in protecting public health by monitoring all drugs' pharmacovigilance in real-world conditions. The FDA's safety information and adverse events reporting program called MedWatch is highlighted. Don't miss out on this opportunity to be informed on post-approval drug considerations. Complete your understanding of the clinical trial process by signing up for Clinical Development 401: Phase IV today

Clinical Development 301: Phase II/III focuses on the purpose and critical differences between well-controlled Phase II and III studies. This class expertly explains the art of trial design and how each protocol measures efficacy via primary and secondary endpoints. Section two focuses on pharmacovigilance and the pivotal role of independent Data Safety Monitoring Boards who exhaustively review data to make critical recommendations about trial continuation, modification, or termination. Clinical Development 301 reveals the regulatory considerations of special designations that can accelerate the drug candidates' development. The class ends with an explanation of the New Drug Application (NDA) and Biologics License Application (BLA) that must be filed with and approved by the FDA to receive drug marketing approval. Join us to continue building your expertise in Clinical Development!